Screening for breast cancer with mammography
67 results
1 - 67
Screening mammography overdiagnoses women with breast cancer- Breast cancer screening benefits overrated
- Breast cancer screening with MRI: more false-positives, more biopsies
- Mammography doesn't decrease cancer-related deaths long-term
- Adding ultrasound to mammography increases false-positive findings without an increase in cancer detection
- Overdiagnosis of breast cancer is common
- Switching to digital mammography for all is too costly
- Numbers to help women understand the benefits/ harms of screening mammography
- Mammography identifies many women who will not benefit from treatment
- Even before the new guidelines, a majority of women stated a preference for breast cancer screening in their 40s
- USPSTF: No routine mammography for women younger than 50 years
- Annual mammography starting at 40 doesn't lower breast CA mortality
- European guidelines on breast cancer screening 2020
- Two thirds of reduction in breast cancer mortality due to therapy advances
- USPSTF recommends mammography every other year for all women 40 to 74 years old
- The risk of breast cancer overdiagnosis is high for older women
- Combined ultrasound + mammogram for high-risk women increases cancer yield
- Overuse alert: Computer aid does not improve mammography accuracy
- Screening for breast cancer: False-positive rates 60% over 10 years
- American College of Physicians: mammography every 2 years between the ages 50 and 74 years
- Small benefit to breast cancer screening for most women
- Guideline: Mammography optional in women 40-49
- Digital mammography: more cancers detected, more recalls, more overdiagnosis than film-based mammography
- Atypia on mammogram does not portend breast cancer in the short term
- Supplemental MRI screening in women with very dense breasts reduces interval cancer rate but may cause overdiagnosis (DENSE)
- No change in mammography rates after 2009 USPSTF update